21/07/2025
PRESS STATEMENT
For Immediate Release
To: All Media Houses
ZAMMSA Secures Major Consignment of Lifesaving Malaria Treatment
Lusaka, July 21, 2025- The Zambia Medicines and Medical Supplies Agency (ZAMMSA) is pleased to announce a significant milestone in the national fight against malaria with the arrival of a critical consignment of lifesaving medication.
On Friday, July 18, 2025, ZAMMSA received 100,000 vials of WHO-prequalified Artesunate 60mg, a cornerstone medicine in the treatment of severe malaria. This shipment forms part of a ZMW 31 million procurement contract, aimed at strengthening the availability of essential antimalarial commodities across the country.
This latest delivery follows the successful receipt of an earlier consignment of 8,400 vials, bringing the total received so far to over 108,400 vials. These vital supplies will immediately bolster the capacity of health facilities, particularly in high-burden areas, to effectively manage and treat severe malaria cases.
ZAMMSA further wishes to inform the public and stakeholders that the remaining 244,600 vials are currently in transit from China and are expected to arrive in the coming days. The Agency remains fully engaged with its supply chain partners to ensure timely and uninterrupted delivery of all essential health commodities.
This effort underscores ZAMMSA’s unwavering commitment to supporting the Ministry of Health in achieving a malaria-free Zambia. By ensuring the consistent availability of effective treatments, ZAMMSA continues to play a pivotal role in safeguarding public health and advancing national health security.
For further information, please contact:
Bradley Chingobe
Senior Manager – Corporate Communications
Zambia Medicines and Medical Supplies Agency (ZAMMSA)